医学
前列腺癌
肿瘤科
前列腺
癌症研究
阉割
内科学
癌症
激素
作者
Oliver Sartor,Johann S. de Bono,Kim N.,Karim Fizazi,Ken Herrmann,Kambiz Rahbar,Scott T. Tagawa,Luke T. Nordquist,Nitin Vaishampayan,Ghassan El‐Haddad,Chandler H. Park,Tomasz M. Beer,Alison Armour,Wendy J. Pérez-Contreras,Michelle DeSilvio,Euloge Kpamegan,Germo Gericke,Richard A. Messmann,Michael J. Morris,Bernd J. Krause
标识
DOI：10.1056/nejmoa2107322
摘要
Metastatic castration-resistant prostate cancer remains fatal despite recent advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic castration-resistant prostate cancer. Lutetium-177 (177Lu)–PSMA-617 is a radioligand therapy that delivers beta-particle radiation to PSMA-expressing cells and the surrounding microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
科研助手6
昏睡的蟠桃
cdercder
pluto
落叶
平常的毛豆
椰子在长江送礼物
科研小民工
nozero
iNk
back you up
pcr163
彭于彦祖
机灵柚子
zho
illusion2019
qiao
竹筏过海
jenningseastera
皖公网安备34019202002308
